Welcome to our dedicated page for Acadia Healthcar news (Ticker: ACHC), a resource for investors and traders seeking the latest updates and insights on Acadia Healthcar stock.
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a behavioral healthcare company that operates a large network of inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, comprehensive treatment centers and outpatient clinics across the United States and Puerto Rico. This news page aggregates company-specific updates and disclosures that help investors and observers follow developments in Acadia’s behavioral healthcare operations and corporate activities.
News related to ACHC often includes quarterly earnings releases, updates to financial guidance, and details on revenue performance by service type, such as acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers and residential treatment centers. The company also issues news about capital expenditure plans, bed additions, and development activity, including the opening of new hospitals, expansions of existing facilities and the addition of new comprehensive treatment centers.
Acadia’s news flow features announcements about participation in healthcare and investor conferences hosted by firms such as J.P. Morgan, UBS and Jefferies, where members of senior management discuss strategy, capital allocation and operating performance. Press releases may also cover executive leadership changes, including appointments and transitions in key roles like the Chief Financial Officer and Chief Operating Officer, as well as statements from the company regarding its approach to shareholder value and governance.
Other notable news items can include updates on professional and general liability reserves, securities litigation settlements, and responses to public letters from shareholders who comment on strategy and governance. By reviewing the ACHC news feed on this page, users can monitor Acadia’s reported operating trends, strategic priorities, capital plans and governance developments over time.
Acadia Healthcare (NASDAQ: ACHC) reported Q4 2025 revenue of $821.5M (up 6.1% YoY) and full-year 2025 revenue of $3.313B (up 5.0%). The company recorded a non-cash $996.2M goodwill impairment, producing a GAAP net loss per diluted share of $13.02 for Q4.
Acadia posted Q4 Adjusted EBITDA of $99.8M and provided 2026 guidance: revenue $3.37–3.45B, Adjusted EBITDA $575–610M, and adjusted EPS $1.30–1.55.
Acadia Healthcare (NASDAQ: ACHC) will participate in three investor conferences in March 2026 with scheduled presentations and live webcasts. Presentations: Raymond James on March 2 at 11:35 a.m. ET, Leerink on March 9 at 3:40 p.m. ET, and Barclays on March 10 at 12:00 p.m. ET.
A live webcast and a replay available for 30 days will be accessible via the company website under the Investors section.
Acadia Healthcare (NASDAQ: ACHC) will release its fourth quarter and year-end 2025 results on Wednesday, February 25, 2026, before the market opens.
The company will host a conference call with institutional investors and analysts on February 25, 2026 at 9:00 a.m. ET, with a live webcast available on the company’s Investors page and a replay for 30 days.
Acadia Healthcare (NASDAQ: ACHC) appointed Debra K. Osteen as Chief Executive Officer and added her to the Board, effective immediately, with Chris Hunter departing the company and its Board. The Board said it will conduct a comprehensive search for a long-term successor while Osteen leads the company. The company reaffirms its full-year 2025 guidance, expecting revenue $3.28B–$3.30B, Adjusted EBITDA $601M–$611M, and adjusted EPS $1.94–$2.04. Management previously reiterated guidance at the J.P. Morgan Healthcare Conference on January 13, 2026. The company noted it cannot reconcile projected Adjusted EBITDA and adjusted EPS to GAAP due to unknown transaction-related expenses and their tax effects.
Acadia Healthcare (NASDAQ: ACHC) will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, January 12-15, 2026. The company’s presentation is scheduled for Tuesday, January 13, 2026 at 5:15 p.m. PT / 7:15 p.m. CT and will be webcast live on Acadia’s investor website.
A replay will be available on the company website for 30 days following the presentation. Investors can access the live webcast via the Investors section at www.acadiahealthcare.com.
Acadia Healthcare (NASDAQ: ACHC) updated its professional and general liability (PLGL) reserves after a third-party actuarial review, lowering 2025 guidance. The company now expects 2025 Adjusted EBITDA $601M–$611M (previously $650M–$660M) and Adjusted EPS $1.94–$2.04 (previously $2.35–$2.45), a reduction of $49M to EBITDA and $0.41 to EPS driven entirely by higher PLGL costs.
Key PLGL figures: projected 2025 PLGL expense ~$116M vs $54M in 2024 (+$62M); 168% increase in 2025 policy-year claim frequency; year-end 2025 net PLGL liability expected to be $145M–$165M (vs $78M at 12/31/2024); 2026 PLGL expense forecasted at $100M–$110M.
Acadia Healthcare (NASDAQ: ACHC) will participate in a fireside chat at the UBS Global Healthcare Conference in Palm Beach Gardens, Florida, running November 9–12, 2025.
The company’s presentation will be webcast live on Tuesday, November 11, 2025 at 1:45 p.m. Central / 2:45 p.m. Eastern and will be accessible via the Investors section of the company website. A replay will be available on the website for 30 days following the event.
Acadia Healthcare (NASDAQ: ACHC) reported Q3 2025 revenue of $851.6M, up 4.4% year-over-year, with same-facility revenue +3.7% and same-facility admissions +3.3%.
Adjusted EBITDA was $173.0Mrevenue $3.28–3.30B, Adjusted EBITDA $650–660M, and adjusted EPS $2.35–2.45.
Acadia added 429 beds in Q3 (908 YTD) and expects 945–1,076 bed additions for 2025. Management changes include CFO Todd Young joining Oct 27 and COO Dr. Nasser Khan resigning effective Nov 3. Cash was $118.7M with $786.7M available on the $1.0B revolver.
Acadia Healthcare (NASDAQ: ACHC) will release third quarter 2025 results on Wednesday, November 5, 2025 after market close. A conference call with institutional investors and analysts is scheduled for 9:00 a.m. ET on Thursday, November 6, 2025.
A live webcast will be available in the Investors section at www.acadiahealthcare.com and the webcast replay will remain accessible for 30 days.
Acadia (NASDAQ: ACHC) appointed Todd Young as Chief Financial Officer, effective October 27, 2025. Young brings roughly 25 years of financial and healthcare experience, most recently serving as CFO at Elanco where he helped build the finance organization after the company separated from Eli Lilly. He previously served as CFO of ACADIA Pharmaceuticals and holds a bachelor’s in economics and a law degree. Tim Sides, interim CFO since August 2025, will return to Senior Vice President, Operations Finance. Leadership says Young will focus on capital allocation, treasury, operational efficiency, and supporting disciplined growth in behavioral healthcare access and outcomes.